查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
自闭症谱系障碍治疗市场规模、份额和趋势分析报告:按治疗类型（兴奋剂、抗精神病药）、应用、分销渠道、地区、细分市场预测 2023-2030 年
市场调查报告书
商品编码
1178547

自闭症谱系障碍治疗市场规模、份额和趋势分析报告:按治疗类型（兴奋剂、抗精神病药）、应用、分销渠道、地区、细分市场预测 2023-2030 年

Autism Spectrum Disorder Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Stimulants, Antipsychotic Drugs), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

自闭症谱系障碍治疗市场的增长和趋势

根据 Grand View Research, Inc. 的最新报告，从 2023 年到 2030 年，全球自闭症谱系障碍治疗市场规模将以 6.1% 的复合年增长率扩大，到 2030 年将达到 32.8 亿美元。学术研究和製药公司管道中的许多实验性自闭症谱系障碍 (ASD) 药物评估了关于基因指纹和大脑如何促进自闭症发展的重要理论。管道药物包括来自 Axial Therapeutics 的 AB-2004 和 AB-2004 PTR，来自 Zynerva Pharmaceuticals 的 Zygel 和来自 Impel Pharmaceuticals 的 INP105（Olanzapine）。

2022 年 7 月，Impel Pharmaceuticals Inc.在评估 INP-105治疗自闭症谱系障碍（ASD）青少年急性激越的 2a 期试验中启动了首例患者给药。凭藉其 POD（精确嗅觉输送）技术，该公司可以在不注射的情况下将药物输送到鼻尖，增加药物吸收。因此，药物输送技术的进步有望推动市场。

2020 年 5 月，HARMAN International 和 F. Hoffmann-La Roche Ltd. 建立全球合作伙伴关係，为 ASD 患者开发数字治疗平台。在这一合作伙伴关係下，Harman 和 Samsung 将其广泛的技术与 F. Hoffmann-La Roche Ltd. 在神经科学方面的领导地位相结合，开发治疗 ASD 的创新疗法。

提高对自闭症谱系障碍研发的认识和资金预计将对市场增长产生积极影响。例如，罗马第一大学将每年 4 月 2 日定为世界自闭症意识日，旨在提高医生和患者对该疾病及其治疗益处的认识。此外，在 2022 年 11 月，Defiance County Board of Developmental Disabilities/Good Samaritan School 和 Andrew Jimenez Autism Foundation 将从 Buckeye Roofing and Exteriors Owners 那里获得 1000 美元，以支持提高人们对 ASD 的认识的努力。捐赠并随后为市场增长创造机会.

自闭症谱系障碍治疗市场报告重点

按治疗类型划分，兴奋剂部分在 2022 年所占份额最大。这可以归因于 FDA 批准的用于疾病症状管理的兴奋剂的市场可用性。

从应用来看，由于自闭症发病率上升，自闭症领域在 2022 年占据了市场主导地位。三项队列研究发现，截至 2021 年 5 月，ASD 发病率超过人口的 3%

到 2022 年，医院药房部门将占据第二大份额。这种增长可归因于诊断和治疗该病患者的住院人数增加。

由于医疗保健专业人员对自闭症谱系障碍治疗的高度认识、治疗药物的可用性以及疾病流行率的增加等因素，北美在 2022 年主导了全球市场

目录

第一章 调查方法和范围

  • 市场细分和范围
    • 段范围
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 第一次调查的内容
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法:产品流方法
  • 调查假设
  • 二级信息列表
  • 缩略语表
  • 目的

第二章执行摘要

  • 市场快照
  • 段快照
  • 争用快照

3 自闭症谱系障碍治疗:市场变量、趋势和范围

  • 市场系列展望
    • 中枢神经系统药物市场
  • 绘製渗透率和增长前景
  • 监管状况
  • 市场动态
  • 市场驱动力分析
    • 自闭症患病率增加
    • 提高医生和患者对 ASD 的认识
    • 增加对 ASD 研究和开发的资助
  • 市场约束因素分析
    • 缺乏批准的药物
    • 未能将靶向治疗从临床前转化为临床
  • PESTEL 分析
  • 行业分析——波特五力
  • 管道分析

4 自闭症谱系障碍治疗市场:细分分析，按治疗类型，2018-2030 年（百万美元）

  • 自闭症谱系障碍治疗市场:治疗类型变化分析
  • 抗精神病药
    • 选择性血清素再摄取抑製剂
    • 兴奋剂
    • 安眠药
    • 其他

5. 自闭症谱系障碍治疗市场:细分分析，按应用，2018-2030 年（百万美元）

  • 自闭症谱系障碍治疗市场:应用差异分析
  • 自闭症
  • 阿斯伯格综合症
  • 广泛性发育障碍
  • 其他

6 自闭症谱系障碍治疗市场:细分分析，按分销渠道，2018-2030 年（百万美元）

  • 自闭症谱系障碍治疗市场:分销渠道的变化分析
  • 医院药房
  • 零售药店
  • 网上药店

7. 欧洲自闭症谱系障碍治疗市场:按药物类别、应用、给药途径和分销渠道进行区域估计和趋势分析

  • 北美
    • SWOT分析
    • 美国
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 加拿大
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
  • 欧洲
    • SWOT分析
    • 英国
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 处方和配药场景
    • 德国
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 法国
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 意大利
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 西班牙
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 丹麦
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 瑞典
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 挪威
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 欧洲其他地区
  • 亚太地区
    • SWOT分析
    • 日本
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 处方和配药场景
    • 中国
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 印度
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 澳大利亚
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 韩国
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 泰国
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 亚太地区其他国家
  • 拉丁美洲
    • SWOT分析
    • 巴西
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
      • 处方和配药场景
    • 墨西哥
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 阿根廷
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
  • 中东和非洲 (MEA)
    • SWOT分析
    • 南非
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 沙特阿拉伯
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 阿拉伯联合酋长国
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • 科威特
      • 国家动态
      • 目标疾病的患病率
      • 竞争情景
      • 监管框架
      • 赎回场景
    • MEA 的其余部分

8 自闭症谱系障碍治疗市场:竞争分析

  • 主要市场进入者的最新发展和影响分析
    • 新产品发布
    • 併购
    • 许可协议
    • 会议和活动
  • 公司分类
    • 创新者
    • 市场领导者
  • 供应商情况
    • 主要经销商及渠道合作伙伴名单
    • 主要客户
  • 上市公司
    • 2022 年主要参与者的市场份额分析
    • 公司市场分析
    • 热图分析
    • 竞争仪錶盘分析
      • 市场差异化因素
  • 民营企业
    • 主要初创企业名单
    • 区域网络图
  • 公司简介
    • Curemark LLC
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Bristol-Myers Squibb Company
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Merck & Co., Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Novartis AG
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Eli Lilly and Company
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Pfizer Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Johnson & Johnson Services, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Otsuka Pharmaceutical Co., Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Yamo Pharmaceuticals
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • F. Hoffmann-La Roche Ltd.
      • 公司简介
      • 产品基准
      • 战略举措
    • Axial Therapeutics Inc.
      • 公司简介
      • 产品基准
      • 战略举措
Product Code: GVR-4-68040-009-9

Autism Spectrum Disorder Treatment Market Growth & Trends:

The global autism spectrum disorder treatment market size is expected to reach USD 3.28 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% from 2023 to 2030. Many of the experimental autism spectrum disorder (ASD) drugs in the academic studies and pharma pipeline are assessing important theories about how the genetic fingerprint and brain contribute to the development of autism. Some of the pipeline drugs include AB-2004 & AB-2004 PTR by Axial Therapeutics, Inc., Zygel by Zynerba Pharmaceuticals, Inc., and INP105 (Olanzapine) by Impel Pharmaceuticals Inc.

In July 2022, Impel Pharmaceuticals Inc. initiated the first patient dose in phase 2a study evaluating INP-105 to treat acute agitation in adolescents with autism spectrum disorder (ASD). The company uses its Precision Olfactory Delivery (POD) technology to deliver medicine to the upper nasal part and increase the absorption of the drug, without the need for injection. Thus, technological advancement in drug delivery is anticipated to drive the market.

In May 2020, HARMAN International and F. Hoffmann-La Roche Ltd. entered into a global partnership to develop a digital therapeutic platform for individuals with ASD. Under this partnership, Harman and Samsung combined their extensive technology with F. Hoffmann-La Roche Ltd.'s leadership in neuroscience to develop innovative therapies for the treatment of ASD.

Rising awareness and funding for research and development of autism spectrum disorder are expected to positively contribute to the growth of the market. For instance, the Sapienza Universita di Roma every year celebrates the 2nd of April as 'World Autism Awareness Day' with an aim to increase awareness about the disease and its treatment benefits among physicians and patients. Furthermore, in November 2022, the Defiance County Board of Developmental Disabilities/Good Samaritan School and the Andrew Jimenez Autism Fund received a donation of USD 1000 from Buckeye Roofing and Exteriors owner to support the efforts to raise awareness about ASD, subsequently creating an opportunity for the market growth.

Autism Spectrum Disorder Treatment Market Report Highlights:

  • By treatment type, the stimulants segment accounted for the largest share in 2022. This can be attributed to the availability of FDA-approved stimulants for the symptom management of disease in the market
  • Based on application, the autistic disorder segment dominated the market in 2022 owing to the rising incidence of the disease. As per the 3 cohort studies, the incidence of ASD was found to be more than 3% of the population as of May 2021
  • The hospital pharmacy segment held the second-largest share in 2022. This growth can be attributed to an increase in inpatient visits for the diagnosis and treatment of patients with disease
  • North America dominated the global market in 2022 owing to factors such as high awareness among healthcare professionals about autism spectrum disorder treatment, the availability of drugs for treatment, and an increase in disease prevalence

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation and Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Snapshot

Chapter 3 Autism Spectrum Disorder Treatment: Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Central Nervous System Therapeutics Market
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Regulatory Landscape
  • 3.4 Market Dynamics
  • 3.5 Market Driver Analysis
    • 3.5.1 Increasing Prevalence of ASD
    • 3.5.2 Increasing Awareness About ASD Among Physicians and Patients
    • 3.5.3 Increasing Funding for ASD R&D
  • 3.6 Market Restraint Analysis
    • 3.6.1 Lack of Approved Drugs
    • 3.6.2 Failures of Preclinical to Clinical Translation of Targeted Treatments
  • 3.7 PESTEL Analysis
  • 3.8 Industry Analysis-Porter's Five Forces
  • 3.9 Pipeline Analysis

Chapter 4 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Treatment Type, 2018 - 2030 (USD Million)

  • 4.1 Autism Spectrum Disorder Treatment Market: Treatment Type Movement Analysis
  • 4.2 Antipsychotic Drugs
    • 4.2.1 Antipsychotic Drugs Market, 2018 - 2030 (USD Million)
    • 4.2.2 Selective Serotonin Reuptake Inhibitors
      • 4.2.2.1 Selective Serotonin Reuptake Inhibitors Market, 2018 - 2030 (USD Million)
    • 4.2.3 Stimulants
      • 4.2.3.1 Stimulants Market, 2018 - 2030 (USD Million)
    • 4.2.4 Sleep Medication
      • 4.2.4.1 Sleep Medication Market, 2018 - 2030 (USD Million)
    • 4.2.5 Others
      • 4.2.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 5.1 Autism Spectrum Disorder Treatment Market: Application Movement Analysis
  • 5.2 Autistic Disorder
    • 5.2.1 Autistic Disorder Market, 2018 - 2030 (USD Million)
  • 5.3 Asperger Syndrome
    • 5.3.1 Asperger Syndrome Market, 2018 - 2030 (USD Million)
  • 5.4 Pervasive Developmental Disorder
    • 5.4.1 Pervasive Developmental Disorder Market, 2018 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

  • 6.1 Autism Spectrum Disorder Treatment Market: Distribution Channel Movement Analysis
  • 6.2 Hospital Pharmacy
    • 6.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3 Retail Pharmacy
    • 6.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4 Online Pharmacy
    • 6.4.1 Online Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 7 Europe Autism Spectrum Disorder Treatment Market: Regional Estimates and Trend Analysis, by Drug Class, Application, Route of Administration, & Distribution Channel

  • 7.1 North America
    • 7.1.1 SWOT Analysis:
      • 7.1.1.1 North America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.1.2 U.S.
      • 7.1.2.1 Country Dynamics
      • 7.1.2.2 Target Disease Prevalence
      • 7.1.2.3 Competitive Scenario
      • 7.1.2.4 Regulatory Framework
      • 7.1.2.5 Reimbursement Scenario
      • 7.1.2.6 U.S. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.1.3 Canada
      • 7.1.3.1 Country Dynamics
      • 7.1.3.2 Target Disease Prevalence
      • 7.1.3.3 Competitive Scenario
      • 7.1.3.4 Regulatory Framework
      • 7.1.3.5 Reimbursement Scenario
      • 7.1.3.6 Canada Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2 Europe
    • 7.2.1 SWOT Analysis:
      • 7.2.1.1 Europe Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2 U.K.
      • 7.2.2.1 Country Dynamics
      • 7.2.2.2 Target Disease Prevalence
      • 7.2.2.3 Competitive Scenario
      • 7.2.2.4 Regulatory Framework
      • 7.2.2.5 Reimbursement Scenario
      • 7.2.2.6 Prescription and Dispensing Scenario
      • 7.2.2.7 U.K. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3 Germany
      • 7.2.3.1 Country Dynamics
      • 7.2.3.2 Target Disease Prevalence
      • 7.2.3.3 Competitive Scenario
      • 7.2.3.4 Regulatory Framework
      • 7.2.3.5 Reimbursement Scenario
      • 7.2.3.6 Germany Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4 France
      • 7.2.4.1 Country Dynamics
      • 7.2.4.2 Target Disease Prevalence
      • 7.2.4.3 Competitive Scenario
      • 7.2.4.4 Regulatory Framework
      • 7.2.4.5 Reimbursement Scenario
      • 7.2.4.6 France Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.5 Italy
      • 7.2.5.1 Country Dynamics
      • 7.2.5.2 Target Disease Prevalence
      • 7.2.5.3 Competitive Scenario
      • 7.2.5.4 Regulatory Framework
      • 7.2.5.5 Reimbursement Scenario
      • 7.2.5.6 Italy Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.6 Spain
      • 7.2.6.1 Country Dynamics
      • 7.2.6.2 Target Disease Prevalence
      • 7.2.6.3 Competitive Scenario
      • 7.2.6.4 Regulatory Framework
      • 7.2.6.5 Reimbursement Scenario
      • 7.2.6.6 Spain Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.7 Denmark
      • 7.2.7.1 Country Dynamics
      • 7.2.7.2 Target Disease Prevalence
      • 7.2.7.3 Competitive Scenario
      • 7.2.7.4 Regulatory Framework
      • 7.2.7.5 Reimbursement Scenario
      • 7.2.7.6 Denmark Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.8 Sweden
      • 7.2.8.1 Country Dynamics
      • 7.2.8.2 Target Disease Prevalence
      • 7.2.8.3 Competitive Scenario
      • 7.2.8.4 Regulatory Framework
      • 7.2.8.5 Reimbursement Scenario
      • 7.2.8.6 Sweden Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.9 Norway
      • 7.2.9.1 Country Dynamics
      • 7.2.9.2 Target Disease Prevalence
      • 7.2.9.3 Competitive Scenario
      • 7.2.9.4 Regulatory Framework
      • 7.2.9.5 Reimbursement Scenario
      • 7.2.9.6 Norway Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.11 Rest of Europe
      • 7.2.11.1 Rest of Europe Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Asia Pacific
    • 7.3.1 SWOT Analysis:
      • 7.3.1.1 Asia PacificAutism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2 Japan
      • 7.3.2.1 Country Dynamics
      • 7.3.2.2 Target Disease Prevalence
      • 7.3.2.3 Competitive Scenario
      • 7.3.2.4 Regulatory Framework
      • 7.3.2.5 Reimbursement Scenario
      • 7.3.2.6 Prescription and Dispensing Scenario
      • 7.3.2.7 Japan Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 China
      • 7.3.3.1 Country Dynamics
      • 7.3.3.2 Target Disease Prevalence
      • 7.3.3.3 Competitive Scenario
      • 7.3.3.4 Regulatory Framework
      • 7.3.3.5 Reimbursement Scenario
      • 7.3.3.6 China Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4 India
      • 7.3.4.1 Country Dynamics
      • 7.3.4.2 Target Disease Prevalence
      • 7.3.4.3 Competitive Scenario
      • 7.3.4.4 Regulatory Framework
      • 7.3.4.5 Reimbursement Scenario
      • 7.3.4.6 India Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5 Australia
      • 7.3.5.1 Country Dynamics
      • 7.3.5.2 Target Disease Prevalence
      • 7.3.5.3 Competitive Scenario
      • 7.3.5.4 Regulatory Framework
      • 7.3.5.5 Reimbursement Scenario
      • 7.3.5.6 Australia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6 South Korea
      • 7.3.6.1 Country Dynamics
      • 7.3.6.2 Target Disease Prevalence
      • 7.3.6.3 Competitive Scenario
      • 7.3.6.4 Regulatory Framework
      • 7.3.6.5 Reimbursement Scenario
      • 7.3.6.6 South Korea Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7 Thailand
      • 7.3.7.1 Country Dynamics
      • 7.3.7.2 Target Disease Prevalence
      • 7.3.7.3 Competitive Scenario
      • 7.3.7.4 Regulatory Framework
      • 7.3.7.5 Reimbursement Scenario
      • 7.3.7.6 Thailand Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8 Rest of APAC
      • 7.3.8.1 Rest of APAC Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Latin America
    • 7.4.1 SWOT Analysis:
      • 7.4.1.1 Latin America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2 Brazil
      • 7.4.2.1 Country Dynamics
      • 7.4.2.2 Target Disease Prevalence
      • 7.4.2.3 Competitive Scenario
      • 7.4.2.4 Regulatory Framework
      • 7.4.2.5 Reimbursement Scenario
      • 7.4.2.6 Prescription and Dispensing Scenario
      • 7.4.2.7 Brazil Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 Mexico
      • 7.4.3.1 Country Dynamics
      • 7.4.3.2 Target Disease Prevalence
      • 7.4.3.3 Competitive Scenario
      • 7.4.3.4 Regulatory Framework
      • 7.4.3.5 Reimbursement Scenario
      • 7.4.3.6 Mexico Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 Argentina
      • 7.4.4.1 Country Dynamics
      • 7.4.4.2 Target Disease Prevalence
      • 7.4.4.3 Competitive Scenario
      • 7.4.4.4 Regulatory Framework
      • 7.4.4.5 Reimbursement Scenario
      • 7.4.4.6 Argentina Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Middle East & Africa (MEA)
    • 7.5.1 SWOT Analysis
      • 7.5.1.1 MEA Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2 South Africa
      • 7.5.2.1 Country Dynamics
      • 7.5.2.2 Target Disease Prevalence
      • 7.5.2.3 Competitive Scenario
      • 7.5.2.4 Regulatory Framework
      • 7.5.2.5 Reimbursement Scenario
      • 7.5.2.6 South Africa Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 Saudi Arabia
      • 7.5.3.1 Country Dynamics
      • 7.5.3.2 Target Disease Prevalence
      • 7.5.3.3 Competitive Scenario
      • 7.5.3.4 Regulatory Framework
      • 7.5.3.5 Reimbursement Scenario
      • 7.5.3.6 Saudi Arabia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 UAE
      • 7.5.4.1 Country Dynamics
      • 7.5.4.2 Target Disease Prevalence
      • 7.5.4.3 Competitive Scenario
      • 7.5.4.4 Regulatory Framework
      • 7.5.4.5 Reimbursement Scenario
      • 7.5.4.6 UAE Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5 Kuwait
      • 7.5.5.1 Country Dynamics
      • 7.5.5.2 Target Disease Prevalence
      • 7.5.5.3 Competitive Scenario
      • 7.5.5.4 Regulatory Framework
      • 7.5.5.5 Reimbursement Scenario
      • 7.5.5.6 Kuwait Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6 Rest of MEA
      • 7.5.6.1 Rest of MEA Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Autism Spectrum Disorder Treatment Market: Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 8.1.1 New Product Launch
    • 8.1.2 Merger and Acquisition
    • 8.1.3 Licensing Agreements
    • 8.1.4 Conferences and Campaigns
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
  • 8.3 Vendor Landscape
    • 8.3.1 List of Key Distributors and Channel Partners
    • 8.3.2 Key Customers
  • 8.4 Public Companies
    • 8.4.1 Key Company Market Share Analysis, 2022
    • 8.4.2 Company Market Position Analysis
    • 8.4.3 Heat Map Analysis
    • 8.4.4 Competitive Dashboard Analysis
      • 8.4.4.1 Market Differentiators
  • 8.5 Private Companies
    • 8.5.1 List of Key Emerging Companies
    • 8.5.2 Regional Network Map
  • 8.6 Company Profiles
      • 8.6.1.Curemark LLC
      • 8.6.1.1 Company Overview
      • 8.6.1.2 Financial Performance
      • 8.6.1.3 Product Benchmarking
      • 8.6.1.4 Strategic Initiatives
    • 8.6.2 Bristol - Myers Squibb Company
      • 8.6.2.1 Company Overview
      • 8.6.2.2 Financial Performance
      • 8.6.2.3 Product Benchmarking
      • 8.6.2.4 Strategic Initiatives
    • 8.6.3 Merck & Co., Inc.
      • 8.6.3.1 Company Overview
      • 8.6.3.2 Financial Performance
      • 8.6.3.3 Product Benchmarking
      • 8.6.3.4 Strategic Initiatives
    • 8.6.4 Novartis AG
      • 8.6.4.1 Company Overview
      • 8.6.4.2 Financial Performance
      • 8.6.4.3 Product Benchmarking
      • 8.6.4.4 Strategic Initiatives
    • 8.6.5 Eli Lilly and Company
      • 8.6.5.1 Company Overview
      • 8.6.5.2 Financial Performance
      • 8.6.5.3 Product Benchmarking
      • 8.6.5.4 Strategic Initiatives
    • 8.6.6 Pfizer Inc.
      • 8.6.6.1 Company Overview
      • 8.6.6.2 Financial Performance
      • 8.6.6.3 Product Benchmarking
      • 8.6.6.4 Strategic Initiatives
    • 8.6.7 Johnson & Johnson Services, Inc.
      • 8.6.7.1 Company Overview
      • 8.6.7.2 Financial Performance
      • 8.6.7.3 Product Benchmarking
      • 8.6.7.4 Strategic Initiatives
    • 8.6.8 Otsuka Pharmaceutical Co., Ltd.
      • 8.6.8.1 Company Overview
      • 8.6.8.2 Financial Performance
      • 8.6.8.3 Product Benchmarking
      • 8.6.8.4 Strategic Initiatives
    • 8.6.9 Yamo Pharmaceuticals
      • 8.6.8.1 Company Overview
      • 8.6.9.2 Financial Performance
      • 8.6.9.3 Product Benchmarking
      • 8.6.9.4 Strategic Initiatives
    • 8.6.10 F. Hoffmann - La Roche Ltd.
      • 8.6.10.1 Company Overview
      • 8.6.10.2 Product Benchmarking
      • 8.6.10.3 Strategic Initiatives
    • 8.6.11 Axial Therapeutics Inc.
      • 8.6.11.1 Company Overview
      • 8.6.11.2 Product Benchmarking
      • 8.6.11.3 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global Autism Spectrum Disorder Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 6 Global Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 8 North America Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 10 North America Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 12 U.S. Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 Canada Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18 Europe Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 20 Europe Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Europe Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22 Germany Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 23 Germany Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Germany Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 U.K. Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 26 U.K. Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 U.K. Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 France Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 29 France Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 France Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 Italy Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 32 Italy Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Italy Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 Spain Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 35 Spain Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Denmark Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Sweden Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 41 Sweden Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Sweden Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Norway Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 44 Norway Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Japan Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 51 Japan Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Japan Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 China Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 54 China Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 China Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 India Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 57 India Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 India Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 South Korea Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 60 South Korea Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 South Korea Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Australia Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 63 Australia Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Australia Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65 Thailand Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 66 Thailand Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Thailand Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 68 Latin America Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 70 Latin America Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 Brazil Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 73 Brazil Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Brazil Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 Mexico Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 76 Mexico Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Mexico Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 78 Argentina Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 79 Argentina Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 88 South Africa Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 89 South Africa Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 South Africa Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 91 UAE Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 92 UAE Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Autism Spectrum Disorder Treatment Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value - Chain - Based Sizing & Forecasting
  • Fig. 7 QFD Modeling For Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Commodity Flow Analysis
  • Fig. 10 Market Snapshot (2022) (USD Million)
  • Fig. 11 Segment Snapshot (2022) (USD Million)
  • Fig. 12 Segment Snapshot (2022) (USD Million)
  • Fig. 13 Competitive Snapshot
  • Fig. 14 Penetration and Growth Prospect Mapping
  • Fig. 15 Autism Spectrum Disorder Treatment Market Driver Impact
  • Fig. 16 Autism Spectrum Disorder Treatment Market Restraint Impact
  • Fig. 17 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 18 Porter's Five Forces Analysis
  • Fig. 19 Autism Spectrum Disorder Treatment Market: Treatment Type Outlook and Key Takeaways
  • Fig. 20 Autism Spectrum Disorder Treatment Market: Treatment Type Movement Analysis
  • Fig. 21 Antipsychotic Drugs Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Antimetabolites Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Selective Serotonin Reuptake Inhibitors Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 24 StimulantsMarket Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sleep Medications Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 26 OthersMarket Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Autism Spectrum Disorder Treatment Market: Application Outlook and Key Takeaways
  • Fig. 28 Autism Spectrum Disorder Treatment Market: Application Movement Analysis
  • Fig. 29 Autistic Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Asperger Syndrome Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Pervasive Developmental Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 32OthersMarket Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Autism Spectrum Disorder Treatment Market: Distribution Channel Outlook and Key Takeaways
  • Fig. 34 Autism Spectrum Disorder Treatment Market: Distribution Channel Movement Analysis
  • Fig. 35 Hospital Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Retail Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Marketplace: Key Takeaways
  • Fig. 39 North America: SWOT analysis
  • Fig. 40 North America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Country Dynamics
  • Fig. 42 U.S. Target Disease Prevalence
  • Fig. 43 U.S. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Country Dynamics
  • Fig. 43 Canada Target Disease Prevalence
  • Fig. 44 Canada Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Europe: SWOT analysis
  • Fig. 46 Europe Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Country Dynamics
  • Fig. 48 Germany Target Disease Prevalence
  • Fig. 49 Germany Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 U.K. Country Dynamics
  • Fig. 51 U.K. Target Disease Prevalence
  • Fig. 52 U.K. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 France Country Dynamics
  • Fig. 54 France Target Disease Prevalence
  • Fig. 55 France Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Italy Country Dynamics
  • Fig. 57 Italy Target Disease Prevalence
  • Fig. 58 Italy Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Spain Country Dynamics
  • Fig. 60 Spain Target Disease Prevalence
  • Fig. 61 Spain Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark Country Dynamics
  • Fig. 63 Denmark Target Disease Prevalence
  • Fig. 64 Denmark Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Sweden Country Dynamics
  • Fig. 66 Sweden Target Disease Prevalence
  • Fig. 67 Sweden Autism Spectrum Disorder Treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Norway Country Dynamics
  • Fig. 69 Norway Target Disease Prevalence
  • Fig. 70 Norway Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Rest of Europe Autism Spectrum Disorder Treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific: SWOT Analysis
  • Fig. 75 Asia Pacific Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Japan Country Dynamics
  • Fig. 77 Japan Target Disease Prevalence
  • Fig. 78 Japan Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 China Country Dynamics
  • Fig. 80 China Target Disease Prevalence
  • Fig. 81 China Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 India Country Dynamics
  • Fig. 83 India Target Disease Prevalence
  • Fig. 84 India Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Australia Country Dynamics
  • Fig. 86 Australia Target Disease Prevalence
  • Fig. 87 Australia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 South Korea Country Dynamics
  • Fig. 89 South Korea Target Disease Prevalence
  • Fig. 90 South Korea Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Thailand Country Dynamics
  • Fig. 92 Thailand Target Disease Prevalence
  • Fig. 93 Thailand Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Rest of APAC Autism Spectrum Disorder Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Latin America (LATAM): SWOT Analysis
  • Fig. 98 Latin America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Brazil Country Dynamics
  • Fig. 100 Brazil Target Disease Prevalence
  • Fig. 101 Brazil Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Mexico Country Dynamics
  • Fig. 103 Mexico Target Disease Prevalence
  • Fig. 104 Mexico Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Argentina Country Dynamics
  • Fig. 106 Argentina Target Disease Prevalence
  • Fig. 107 Argentina Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Rest of LATAM Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Middle East & Africa (MEA): SWOT Analysis
  • Fig. 112 Middle East & Africa (MEA) Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 South Africa Country Dynamics
  • Fig. 114 Target Disease Prevalence
  • Fig. 115 South Africa Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 116 Saudi Arabia Country Dynamics
  • Fig. 117 Saudi ArabiaTarget disease prevalence
  • Fig. 118 Saudi Arabia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 UAE Country Dynamics
  • Fig. 120 UAE Target Disease Prevalence
  • Fig. 121 UAE Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 Kuwait Country Dynamics
  • Fig. 123 Kuwait Target Disease Prevalence
  • Fig. 124 Kuwait Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 127 Rest of MEA Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 128 Heat Map Analysis
  • Fig. 129 Strategic Framework